When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 79 Hits
  • Search Condition : Filter (MeSH = Pancreatic Neoplasms / metabolism)
Species Resource Title
Human and Animal Cells 409B2(HPS0076) Tumor-associated macrophages derived from cancer stem cells.
Human and Animal Cells PANC-1(RCB2095) Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer.
Human and Animal Cells MIA Paca2(RCB2094) , PANC-1(RCB2095) α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) , PK-8(RCB2700) The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.
Human and Animal Cells PANC-1(RCB2095) Structure-activity relationship and mechanistic study on guggulsterone derivatives; Discovery of new anti-pancreatic cancer candidate.
Human and Animal Cells 293T(RCB2202) SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2.
Human and Animal Cells PANC-1(RCB2095) , MIA Paca2(RCB2094) PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis.
Human and Animal Cells PANC-1(RCB2095) GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.
Human and Animal Cells PK-1(RCB1972) , KLM-1(RCB2138) Avarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK-eIF2α-CHOP signaling.
Human and Animal Cells KP4(RCB1005) SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.
Human and Animal Cells PK-59(RCB1901) PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Human and Animal Cells PANC-1(RCB2095) MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction Between Pancreatic Cancer Cells and Stellate Cells.
Human and Animal Cells PK-1(RCB1972) , KLM-1(RCB2138) Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target.
Human and Animal Cells A549(RCB0098) Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
Human and Animal Cells MIA Paca2(RCB2094) Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.
Human and Animal Cells hPSC-1(RCB3586) Fatty Acid-Mediated Stromal Reprogramming of Pancreatic Stellate Cells Induces Inflammation and Fibrosis That Fuels Pancreatic Cancer.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer.
Human and Animal Cells PANC-1(RCB2095) ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.
Human and Animal Cells KLM-1(RCB2138) Combining the antimesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cells.
Human and Animal Cells PK-1(RCB1972) , PK-8(RCB2700) , PK-45P(RCB2141) , PK-59(RCB1901) , KP4(RCB1005) , NOR-P1(RCB2139) , T3M-4(RCB1021) Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer.